Turn ASCO data into business-critical insights. 30 high-prescribing hem/oncs analyze 8-10 AML abstracts to help you prepare for what’s next. Take the guesswork out of understanding changes in prescribing behavior for aspacytarabine, azacitidine (oral), olutasidenib among others. Get your 60+ slide report.

Acute Myeloid Leukemia Report ASCO 2021

American Society of Clinical Oncology

Virtual Meeting
Jun 4 to Jun 8

Share: